ACSL4

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, ACSL4 mutation is significantly associated with the RNA expression of many other genes, with 4,055 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible ACSL4-associated genes across cancer lineages are IPO5P1, RNU6-709P, and MIR95. Each is linked with ACSL4 in more than 1 cancer types. Because this analysis shows association rather than direction, both ACSL4-to-partner and partner-to-ACSL4 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, IPO5P1 grouped by ACSL4-low versus ACSL4-high in UCEC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (ACSL4→partner) and Y-score (partner→ACSL4) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECIPO5P1 →+0.308+1.684.008.00232
CESCRNU6-709P →+0.150+5.367<.001<.00132
CESCMIR95 →+0.293+2.967<.001.00532
COADRPL32P21 →+0.346+3.061<.001.00532
BRCAHMGB3P23 →+0.038+4.317<.001.00732
BRCAMTND5P17 →+0.027+4.362.001<.00132
Each partner links to its Q-omics profile. Showing the 6 strongest of 4,055 associations by consensus.

IPO5P1 by ACSL4 expression — UCEC

Box plot of IPO5P1 in ACSL4-low vs ACSL4-high samples in UCEC.

Explore this box plot interactively →

Exploration